INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 08,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
349
COMPREHENSIVE APPROACH TO THE COURSE AND TREATMENT OF
CONJUNCTIVITIS AGAINST THE BACKGROUND OF METABOLIC SYNDROME
Boboeva Ra'no Rahimovna
Bukhara State Medical Institute named after Abu Ali ibn Sino.
Bukhara, Uzbekistan.
e-mail:
Bekmurodova Orzigul Kamolovna
Bukhara State Medical Institute named after Abu Ali ibn Sino.
Bukhara, Uzbekistan.
e-mail: bekmurodovaorzigul@bsmi.uz
Annotation.
Metabolic syndrome is a combination of pathological conditions, including insulin
resistance, arterial hypertension, hyperlipidemia, and abdominal obesity, which significantly
affect various div systems. One of the important aspects of metabolic syndrome is its impact
on eye health, especially on the development of inflammatory diseases such as conjunctivitis.
Conjunctivitis against the background of metabolic syndrome can have various clinical
manifestations, including redness, itching, tearing, and eye swelling. The pathogenesis of these
diseases includes both the direct effect of metabolic disorders and the secondary weakening of
immune defense. Endocrine and metabolic disorders contribute to changes in the structure of
tear fluid, which increases susceptibility to inflammation and infections.
A comprehensive approach to treating conjunctivitis against the background of metabolic
syndrome includes both systemic and local therapeutic methods. The most important areas of
treatment are the correction of metabolic disorders using drugs aimed at reducing blood sugar
levels, improving lipid metabolism, and normalizing blood pressure. Local treatment of
conjunctivitis includes the appointment of anti-inflammatory and antiseptic medications, as
well as the use of medications to improve the condition of the tear film. Thus, effective
treatment of conjunctivitis in patients with metabolic syndrome requires an individual approach,
which includes both the correction of the underlying disease and the use of specific therapy to
reduce inflammation and prevent complications.
Keywords:
Conjunctivitis, metabolic syndrome, complex treatment, influence of metabolic
syndrome, diabetic retinopathy, insulin resistance
Аннотация:
Метаболический синдром представляет собой совокупность патологических
состояний,
включающих
инсулинорезистентность,
артериальную
гипертензию,
гиперлипидемию и абдоминальное ожирение, которые оказывают значительное влияние
на различные системы организма. Одним из важных аспектов метаболического синдрома
является его влияние на здоровье глаз, особенно на развитие воспалительных
заболеваний, таких как конъюнктивит. Конъюнктивиты на фоне метаболического
синдрома могут иметь различные клинические проявления, включая покраснение, зуд,
слезотечение и отечность век. Патогенез этих заболеваний включает как прямое
воздействие метаболических нарушений, так и вторичное ослабление иммунной защиты.
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 08,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
350
Эндокринные и обменные нарушения способствуют изменению структуры слезной
жидкости, что увеличивает предрасположенность к воспалению и инфекциям.
Комплексный подход к лечению конъюнктивитов на фоне метаболического синдрома
включает как системные, так и местные терапевтические методы. Важнейшими
направлениями лечения являются коррекция метаболических нарушений с
использованием препаратов, направленных на снижение уровня сахара в крови,
улучшение липидного обмена и нормализацию артериального давления. Местное
лечение
конъюнктивита
включает
назначение
противовоспалительных
и
антисептических препаратов, а также использование препаратов для улучшения
состояния слезной пленки. Таким образом, эффективное лечение конъюнктивита у
пациентов с метаболическим синдромом требует индивидуального подхода, который
включает как коррекцию основного заболевания, так и использование специфической
терапии для уменьшения воспаления и предотвращения осложнений.
Ключевые слова:
Конъюнктивит, метаболический синдром, комплексное лечение,
влияние
метаболического
синдрома,
диабетическая
ретинопатия,
инсулинорезистентность.
Аннотация.
Метаболик синдром организмнинг турли тизимларига сезиларли таъсир
кўрсатадиган инсулин қаршилиги, артериал гипертензия, гиперлипидемия ва абдоминал
семизликни ўз ичига олган патологик ҳолатлар тўпламидир. Метаболик синдромнинг
муҳим жиҳатларидан бири унинг кўз саломатлигига, айниқса конъюнктивит каби
яллиғланиш касалликларинингривожланишига таъсиридир. Метаболик синдром
фонидаги конъюнктивитлар турли хил клиник кўринишларга эга бўлиши мумкин,
жумладан, қизариш, қичишиш, кўз ёшланиши ва қовоқларнинг шишиши. Ушбу
касалликларнинг патогенези метаболик бузилишларнинг бевосита таъсирини ҳам,
иммунитет ҳимоясининг иккиламчи заифлашувини ҳам ўз ичига олади. Эндокрин ва
алмашинув бузилишлари суюқлик таркибининг ўзгаришига олиб келади.
Метаболик синдром фонидаги конъюнктивитларни даволашга комплекс ёндашув ҳам
тизимли, ҳам маҳаллий терапевтик усулларни ўз ичига олади. Даволашнинг энг муҳим
йўналишлари қондаги қанд миқдорини камайтириш, липид алмашинувини яхшилаш ва
қон босимини нормаллаштиришга қаратилган дори-дармонларни қўллаш орқали
метаболик
бузилишларни
тузатишдир.
Конъюнктивитни
маҳаллий
даволаш
яллиғланишга қарши ва антисептик дориларни тайинлаш, кўз ёши пардасининг ҳолатини
яхшилаш учун дорилардан фойдаланишни ўз ичига олади. Шундай қилиб, метаболик
синдром билан оғриган беморларда конъюнктивитни самарали даволаш асосий
касалликни тузатишни ҳам, яллиғланишни камайтириш ва асоратларнинг олдини олиш
учун махсус терапиядан фойдаланишни ҳам ўз ичига олган индивидуал ёндашувни талаб
қилади.
Калит сўзлар:
Конъюнктивит, метаболик синдром, комплекс даволаш, метаболик
синдром таъсири, диабетик ретинопатия, инсулинрезистентлик.
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 08,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
351
Metabolic syndrome (MS) is a group of metabolic disorders that includes insulin
resistance, hypertension, dyslipidemia, obesity, and high blood sugar. These disorders are
closely related to the development of various diseases, including eye diseases such as
conjunctivitis. In this regard, it is important to consider a comprehensive approach to the
diagnosis and treatment of conjunctivitis against the background of metabolic syndrome, taking
into account the impact of general metabolic disorders on the condition of the visual organs.
The topic of a comprehensive approach to the course and treatment of conjunctivitis against the
background of metabolic syndrome is very relevant, given modern trends in the field of
medicine and health care.
Metabolic syndrome (MS) includes a number of metabolic disorders such as obesity,
hypertension, dyslipidemia, insulin resistance, which can affect various organs and systems,
including the eyes.
Increase in metabolic syndrome
. In recent decades, there has been an increase in the
number of patients with metabolic syndrome, which is associated with a deterioration in
lifestyle, poor nutrition, physical inactivity and stress. This directly affects the occurrence of
concomitant diseases, including eye diseases. The impact of MS on the immune system.
Metabolic syndrome is accompanied by inflammatory processes in the div, which can lead to
a change in the immune response, including an increased risk of developing inflammation in the
eyes, such as conjunctivitis. Risks of worsening conjunctivitis. People with metabolic syndrome
often have problems with microcirculation, which can make it difficult to treat inflammatory
diseases, including conjunctivitis. In addition, diabetes and other metabolic disorders can
increase the likelihood of infection and slow healing. The need for a comprehensive approach
to treatment. Given the relationship between metabolic syndrome and eye diseases, treatment of
conjunctivitis should be comprehensive. This includes not only the use of local drugs
(antibacterial, antiviral, anti-inflammatory), but also the correction of metabolic disorders with
the help of medications, diet, exercise and other methods aimed at improving the general
condition of the patient.
Early detection and prevention
. Prevention and timely detection of both metabolic syndrome
and eye diseases are important aspects in preventing the development of complications. The use
of screening methods to detect both MS and eye diseases allows for the effective prevention of
disease progression. Metabolic syndrome has a significant impact on eye health, contributing to
the development of various diseases. One such disease is conjunctivitis, an inflammation of the
conjunctiva, the membrane that covers the front of the eyeball and the inside of the eyelids.
Signs of conjunctivitis include redness, itching, swelling, and discharge from the eyes. However,
in patients with metabolic syndrome, the disease can be more severe and prolonged, which is
associated with a number of factors: Insulin resistance can contribute to the development of
chronic inflammatory processes, which can complicate the recovery process during infections.
Systemic inflammation, characteristic of metabolic syndrome, increases the likelihood of
developing conjunctivitis, especially in conditions of a weakened immune response. Dry eyes
and impaired lacrimation are also common in patients with metabolic syndrome, which may be
an additional risk factor for the development of conjunctivitis.
Diagnosis of conjunctivitis in patients with metabolic syndrome requires a
comprehensive approach. In addition to traditional diagnostic methods, such as examination
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 08,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
352
and microbiological examination of eye discharge, the following aspects must be taken into
account: Assessing the patient's general health, identifying signs of metabolic syndrome (high
blood pressure, excess weight, lipid metabolism disorders, increased blood glucose levels).
Assessing the presence of concomitant eye diseases, such as dry eye syndrome, which can
worsen the course of conjunctivitis. Inflammation tests, including C-reactive protein (CRP)
levels and other inflammatory markers, to assess the degree of systemic inflammation.
Treatment of conjunctivitis in patients with metabolic syndrome requires not only an effect on
conjunctival inflammation, but also correction of the underlying metabolic disease. Treatment
should be comprehensive and include the following stages: Anti-inflammatory drugs for the
treatment of conjunctivitis can be used both locally (eye drops, ointments) and systemically
anti-inflammatory drugs. The use of steroidal and non-steroidal anti-inflammatory drugs may
be justified in severe forms of inflammation. Antibiotics and antiseptics in case of bacterial
infection, broad-spectrum antibiotics may be prescribed. It is important to consider the possible
tendency of patients with metabolic syndrome to microflora disturbance, which may affect the
choice of drugs. Moisturizing drops for dry eye syndrome it is important to use moisturizing
preparations to maintain the normal condition of the mucous membrane of the eyes. Eye
hygiene following hygiene recommendations and regularly cleaning the eyelids from dirt helps
reduce inflammation and improve healing processes. Treatment of metabolic syndrome
Correction of metabolic disorders is of key importance in the treatment of conjunctivitis against
the background of metabolic syndrome. It is important to work in the following areas:
Control of blood sugar levels. To improve your health and reduce inflammation, you
need to control your blood glucose levels through diet, exercise, and medication (such as
metformin or insulin).
Correction of lipid metabolism. The use of statins to reduce cholesterol levels in the
blood can reduce inflammation in the div and in the eyes.
Normalization of blood pressure. The use of antihypertensive drugs to control blood
pressure helps reduce the risk of vascular diseases of the eyes.
Diet and physical activity. Eating a balanced diet that includes antioxidants and anti-
inflammatory foods, as well as regular physical activity, can help improve overall metabolism.
A patient’s lifestyle plays an important role in the treatment of both metabolic syndrome and
conjunctivitis.
Lifestyle recommendations include:
• Stopping smoking and limiting alcohol consumption, as these factors can worsen both eye
inflammation and metabolic disorders.
• Reducing stress through relaxation techniques or psychological support.
A comprehensive approach to the treatment of conjunctivitis against the background of
metabolic syndrome includes not only local therapy, but also correction of the underlying
disease. It is important to consider the impact of metabolic disorders on the course of eye
diseases and to apply an integrated approach, including drug treatment, lifestyle changes and
continuous monitoring of the patient's health. Thus, attention to metabolic disorders in the
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 08,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
353
context of the treatment of eye diseases helps to increase the effectiveness of therapy and
improve the quality of life of patients.
Literatures:
1. K.Lekhanont et al. Effect of topical olopatadine and epinastine in the botulinum toxin B-
induced mouse model of dry eye. // J Ocul Pharmacol Ther. 2007 Feb; 23(1): 83-8. D
2. Pan Q. et al. Autologous serum eye drops for dry eye //Cochrane Database of Systematic
Reviews. – 2017. – №. 2.
3. Bielory L., Lien K. W., Bigelsen S. Efficacy and tolerability of newer antihistamines in the
treatment of allergic conjunctivitis //Drugs. – 2005. – Т. 65. – №. 2. – С. 215-228.
4. Azari A. A., Barney N. P. Conjunctivitis: a systematic review of diagnosis and treatment
//Jama. – 2013. – Т. 310. – №. 16. – С. 1721-1730.
5. Owen CG, Shah A, Henshaw K, et al. Topical treatments for seasonal allergic conjunctivitis:
systematic review and meta-analysis of efficacy and effectiveness. //Br J Gen Pract. – 2004. –
v.54(503). – P.451-456.
6. Hwang D. G. et al. A phase III, placebo controlled clinical trial of 0.5% levofloxacin
ophthalmic solution for the treatment of bacterial conjunctivitis //British journal of
ophthalmology. – 2003. – Т. 87. – №. 8. – С. 1004-1009.
7.Boboeva Ranо Rakhimovna. Improvement of Methods of Treatment of Retinal Angiopathies
of Various Etiologies: //Journal of Natural and Medical Education Year 2024;3(2).
8.Бобоева Раъно Рахимовна. Совершенствование методов лечения ангиопатий сетчатки
различной этиологии. //Journal of science in medicine and life. 2024; с. 61-65.
9. Бобоева Раъно Рахимовна. Комплексный подход к течению и лечению
конъюнктивитов на фоне метаболического синдрома .// world scientific research journal
volume-38_issue-1_april-2025 ,84-90ст
